Viridian Therapeutics Ors Inc (VRDN)
Stock-Based Compensation
$16.98M
Quarterly · Period ending: · USD
VRDN Stock-Based Compensation
Latest reported$16.98Mperiod ending
Latest reported$16.98Mperiod ending
VRDN Quarterly Stock-Based Comp ($0.00 → $16.98M)
Quarterly stock-based compensation
High-resolution chart · PNG
VRDN stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 16,984,000 | |
| 13,390,000 | |
| 11,989,000 | |
| 11,250,000 | |
| 10,844,000 | |
| 10,220,000 | |
| 8,975,000 | |
| 8,720,000 | |
| 11,767,000 | |
| 12,688,000 | |
| 26,048,000 | |
| 13,606,000 | |
| 12,302,000 | |
| 15,216,000 | |
| 5,278,000 | |
| 4,943,000 | |
| 4,885,000 | |
| 4,659,000 | |
| 3,491,000 | |
| 3,982,000 | |
| 3,817,000 | |
| 3,175,000 | |
| 1,743,000 | |
| 615,000 | |
| 623,000 | |
| 664,000 | |
| 1,003,000 | |
| 874,000 | |
| 1,075,000 | |
| 1,018,000 | |
| 937,000 | |
| 968,000 | |
| 984,000 | |
| 790,000 | |
| 716,000 | |
| 679,000 | |
| 595,000 | |
| 419,000 | |
| 670,000 | |
| 93,000 | |
| 635,000 | |
| 713,000 | |
| 757,000 | |
| 838,000 | |
| 712,000 | |
| 708,000 | |
| 719,535 | |
| 703,725 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |